A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result.
PHARMACEUTICALS（2023）
关键词
age-related macular degeneration,polypoidal choroidal vasculopathy,intravitreal brolucizumab injection,treat-and-extend,switching
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要